DOCSLIB.ORG

2020 Single Audit Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

State of Washington For the Fiscal Year Ended Schedule of Expenditures of Federal Awards June 30, 2020 (Expressed in whole dollars) Note F: Supplemental Information for Pass-Through Funds Federal State Catalog Agency Award/Contract Expenditure No. No. Pass-Through Entity Name Control Number Amount 10.001 3650 COTTON INCORPORATED WSU003470 183,737 10.025 3600 BOYCE THOMPSON INST FOR PLANT RSCH 19-03 865 10.025 3650 WA STATE RECREAT & CON 182432 24,008 10.170 3650 VIVA FARMS ORSO131825001 4,680 10.200 3650 COLORADO STATE UNIV WSU004075 1,370 10.200 3650 MI ST UNIV RC110588WSU 7,252 10.200 3650 UNIVERSITY OF CALIF A180916S003 687 10.200 3650 UNIVERSITY OF CALIF A180916S004 17,711 10.200 3650 UNIVERSITY OF CALIF A180916S066 27,357 10.200 3650 UNIVERSITY OF CALIF A180916S074 75,070 10.200 3650 UNIVERSITY OF CALIF A180916S076 18,401 10.200 3650 UNIVERSITY OF CALIF A180916S077 3,353 10.200 3650 UNIVERSITY OF CALIF A180916S082 8,811 10.200 3650 UNIVERSITY OF CALIF A201347A010 1,197 10.200 3650 UNIVERSITY OF CALIF A201347S003 5,407 10.200 3650 UNIVERSITY OF CALIF A201347S005 5,255 10.200 3650 UNIVERSITY OF CALIF A201347S029 1,679 10.200 3650 UNIVERSITY OF IDAHO BJKP36SB003 1,122 10.215 3650 MONTANA STATE UNIV G13020W7504 11,131 10.215 3650 MONTANA STATE UNIV G13220W7504 14,214 10.215 3650 MONTANA STATE UNIV G13520W7507 1,266 10.215 3650 MONTANA STATE UNIV G16219W7506 15,536 10.215 3650 MONTANA STATE UNIV G16920W7507 4,328 10.215 3650 MONTANA STATE UNIV G23620W7504 11,811 10.215 3650 MONTANA STATE UNIV G26219W7502 12,286 10.215 3650 UTAH STATE UNIVERSITY 130676002240 -11 10.215 3650 UTAH STATE UNIVERSITY 15089300001266 -13 10.215 3650 UTAH STATE UNIVERSITY 150893169 14,505 F - 215 State of Washington For the Fiscal Year Ended Schedule of Expenditures of Federal Awards June 30, 2020 (Expressed in whole dollars) Note F: Supplemental Information for Pass-Through Funds Federal State Catalog Agency Award/Contract Expenditure No. No. Pass-Through Entity Name Control Number Amount 10.215 3650 UTAH STATE UNIVERSITY 20059200001316 -133 10.215 3650 UTAH STATE UNIVERSITY 200592380 -7 10.215 3650 UTAH STATE UNIVERSITY 200592444 6,463 10.215 3650 UTAH STATE UNIVERSITY 201207511 9,597 10.215 3650 UTAH STATE UNIVERSITY 201207548 60,773 10.215 3650 UTAH STATE UNIVERSITY 201207564 47,387 10.215 3650 UTAH STATE UNIVERSITY 201207568 6,031 10.227 3800 Northwest Indian College NWIC-SA28759-WWU 6,929 10.303 3650 OREGON STATE UNIV C0550AA 4,888 10.304 3650 UNIV OF CA-DAVIS FED 20160379404 57,549 10.307 3650 MONTANA STATE UNIV G19419W7408 117,823 10.307 3650 OR ST UNIV FED C0519AA 51,536 10.307 3650 ORGANIC FRMNG RES FNDN WSU004151 23,393 10.307 3650 UTAH STATE UNIVERSITY 14082302 408 10.307 3650 UTAH STATE UNIVERSITY 202524666 6,662 10.308 3650 UNIVERSITY OF GEORGIA SUB00000421 -30 10.309 3650 CORNELL UNIV 7399910422 32,046 10.309 3650 CORNELL UNIVERSITY 7399910422 574 10.309 3650 CORNELL UNIVERSITY 7961110753 251,591 10.309 3650 CORNELL UNIVERSITY 8198010924 86,918 10.309 3650 MI ST UNIV RC104285L 231,052 10.309 3650 MI ST UNIV RC106347WSU 124,055 10.309 3650 MONTANA STATE UNIV G18219W7553 256,517 10.309 3650 N CAROLINA STATE UNIV 2016149806 102,612 10.309 3650 N CAROLINA STATE UNIV 2017039813 89,973 10.309 3650 PENN STATE UNIVERSITY S000224-NIFA 73 10.309 3650 PENN STATE UNIVERSITY S000224NIFA 26,014 10.309 3650 UNIV OF MINNESOTA H007082509 28,869 F - 216 State of Washington For the Fiscal Year Ended Schedule of Expenditures of Federal Awards June 30, 2020 (Expressed in whole dollars) Note F: Supplemental Information for Pass-Through Funds Federal State Catalog Agency Award/Contract Expenditure No. No. Pass-Through Entity Name Control Number Amount 10.309 3650 UNIVERSITY OF ARKANSAS 9144702 89,195 10.309 3650 UNIVERSITY OF CALIF 20140375704 15,973 10.309 3650 UNIVERSITY OF FLORIDA UFDSP00010606 6,910 10.309 3650 UNIVERSITY OF FLORIDA UFDSP00012310 54,417 10.309 3650 UNIVERSITY OF TN 8500042730 63,020 10.310 3600 WESTERN UNIVERSITY OF HEALTH SCIENCES 20142DRESCHLERNIFAAM01 239,779 10.310 3650 BAYLOR COLL MEDICINE 102117659 246,738 10.310 3650 BOISE ST UNIV FED FLOW 8605PO137170 2,937 10.310 3650 FLORIDA A&M UNIVERSITY C4996 129,257 10.310 3650 MI ST UNIV RC104967WSU 207,906 10.310 3650 N CAROLINA STATE UNIV 2018031801 2,802 10.310 3650 UNIV OF 0RTH TEXAS GF105031 20,743 10.310 3650 UNIV OF IL FED FLOW 07594515343 23,304 10.310 3650 UNIV OF IL FED FLOW 09486017405 38,451 10.310 3650 UNIV OF IL FED FLOW 09974217884 1,014 10.310 3650 UNIVERSITY OF CALIF 20160356617 139,576 10.310 3650 UNIVERSITY OF CALIF A181616S001 75,967 10.310 3650 UNIVERSITY OF FLORIDA UFDSP00011803 73,503 10.310 3650 UNIVERSITY OF IDAHO BGK418SB001 13,096 10.310 3650 UNIVERSITY OF IDAHO BJKP55SB002 -6 10.310 3650 UNIVERSITY OF IDAHO BJKQ80SB001 560,625 10.310 3650 UNIVERSITY OF MARYLAND 58864Z5057201 85,033 10.310 3650 UNIVERSITY OF MN H005365302 1,958 10.310 3650 UNIVERSITY OF VERMONT 29034SUB51754 25,254 10.310 3650 UNIVERSITY OF VERMONT 30122SUBWSU 8,309 10.310 3760 Vermont Univ. 30122 SUB52346 9,852 10.311 3650 VIVA FARMS ORSO130291 2,740 10.328 3650 UNIVERSITY OF IDAHO BLK246SB003 10,430 F - 217 State of Washington For the Fiscal Year Ended Schedule of Expenditures of Federal Awards June 30, 2020 (Expressed in whole dollars) Note F: Supplemental Information for Pass-Through Funds Federal State Catalog Agency Award/Contract Expenditure No. No. Pass-Through Entity Name Control Number Amount 10.328 3650 UNIVERSITY OF TN 9500073538 5,045 10.331 3650 VIVA FARMS 127670002 25,281 10.351 3600 CENTER FOR INCLUSIVE ENTREPRENEURSHIP UW635644 -6 10.351 6990 DSHS 56-32-525954174 46,682 10.351 6990 USDA R094145 58913 5,514 10.443 3650 VIVA FARMS 134303 25,654 10.460 3650 VIVA FARMS 134767 30,208 10.460 3650 VIVA FARMS ORSO132302 -103 10.500 3650 KANSAS STATE UNIV A000983S067 7,579 10.500 3650 KANSAS STATE UNIV S18094 -731 10.500 3650 KANSAS STATE UNIV S19120 15,575 10.500 3650 KANSAS STATE UNIV S19155 14,117 10.500 3650 PENN STATE UNIVERSITY 5968WSUUM3501 3,181 10.500 3650 PURDUE UNIV F9000067402012 20,443 10.500 3650 TEXAS A&M UNIVERSITY M1800199 673 10.561 6990 SBCTC BFET 50% 116-BFET-19 95,859 10.604 3650 ALASKA DEPT OF NAT RES TASC201809 47,648 10.604 3650 UNIVERSITY OF CALIF A193112S004 11,893 10.604 3650 WA APPLE COMMISSION WAC141520 2,519 10.604 3650 WA RED RASPBERRY COMM ORSO130051 3,358 10.674 3650 WILSON ENGINEERING SVC 0100 21,734 10.680 3650 WA ST TREE FRUIT ASSOC 1101 6,341 10.680 3800 Cornell University 87313-11118 2,138 10.684 3600 WORLD WILDLIFE FUND HV72 AM01 18,238 10.912 3650 WHATCOM COUNTY CONSERV 132276001 9,665 10.U01 3650 MONTANA STATE UNIV G10920W7504 32,694 10.U02 3650 OR ST UNIV FED R0783AA 78,777 10.U09 3700 KOMAN Holdings LLC UWPP-07 56 F - 218 State of Washington For the Fiscal Year Ended Schedule of Expenditures of Federal Awards June 30, 2020 Note F: Supplemental Information for Pass-Through Funds (Expressed in whole dollars) Federal State Catalog Agency Award/Contract Expenditure No. No. Pass-Through Entity Name Control Number Amount 11.011 3600 FLORIDA INTERNATIONAL UNIVERSITY 800009482-01UG 16,071 11.011 3600 OPTO-KNOWLEDGE SYSTEMS INC 18120501 15,451 11.011 3600 WOODS HOLE OCEANOGRAPHIC INSTITUTION 24185600 23,336 11.012 3600 ALASKA OCEAN OBSERVING SYSTEM H2400-63 AM06 43,931 11.012 3600 UNIVERSITY OF ALASKA FAIRBANKS UAF 15-0085 AM04 19,954 11.012 3600 UNIVERSITY OF CALIFORNIA SANTA CRUZ A19-0200-S001-P0693599 6,543 11.012 3600 UNIVERSITY OF CALIFORNIA SANTA CRUZ A190200S001P0693599AM0 38,654 11.020 3600 CLEANTECH ALLIANCE UW661740 2,701 11.303 3700 NCWEDD ED17SEA3020076 -1,812 11.407 4770 Pacific Salmon Commission SF-2018-VHP-14A 34,093 11.407 4770 Pacific Salmon Commission SF-2019-I-8 28,615 11.407 4770 Pacific Salmon Commission SF-2019-SP-11 27,861 11.407 4770 Pacific Salmon Commission SF-2019-SP-33 68,349 11.407 4770 Pacific Salmon Commission SF-2019-SP-3A 96,899 11.407 4770 Pacific Salmon Commission WDFW 19-13345 317,392 11.407 4770 Pacific States Marine Fisheries Commission 20-37G 16,208 11.407 4770 Pacific States Marine Fisheries Commission 20-38G 11,350 11.407 4770 Pacific States Marine Fisheries Commission 20-81G 24,843 11.407 4770 Pacific States Marine Fisheries Commission PSMFC #19-68G 65,813 11.407 4770 Pacific States Marine Fisheries Commission PSMFC# 19-52G 29,629 11.407 4770 Pacific States Marine Fisheries Commission PSMFC# 20-126G 3,305 11.407 4770 Pacific States Marine Fisheries Commission PSMFC# 20-76G 100,740 11.417 3600 UNIVERSITY OF CONNECTICUT 364379 AM01 35,980 11.417 3600 UNIVERSITY OF HAWAII MA1310 AM02 23,391 11.417 3800 University of Washington UWSC10408 / BPO30555 22,121 11.417 3800 University of Washington UWSC11837 / BPO47884 6,846 11.417 6990 University of WA 0648-0362 22,821 11.431 3600 OREGON STATE UNIVERSITY NA291A-B AM05 83,205 F - 219 State of Washington For the Fiscal Year Ended Schedule of Expenditures of Federal Awards June 30, 2020 (Expressed in whole dollars) Note F: Supplemental Information for Pass-Through Funds Federal State Catalog Agency Award/Contract Expenditure No.
Recommended publications
  • Budgetpresentation.Univeresity of Pittsburgh 2021.Pdf

    Budgetpresentation.Univeresity of Pittsburgh 2021.Pdf

    One of the most innovative universities in the world — Reuters The top public university in the Northeast — The Wall Street Journal/ Times Higher Education Among the top 20 public schools in the nation — U.S. News & World Report $4.2 Billion in economic impact in Pennsylvania — EI Report Data Budget Presentation to the General Assembly of the Commonwealth of Pennsylvania 2021–22 CONTENTS CHANCELLOR’S STATEMENT ...................................................................................1 OUR IMPACT .....................................................................................................................2 The Student Experience ..................................................................................................3 Outstanding Faculty .........................................................................................................5 Research Strength ............................................................................................................5 Combating the Opioid Crisis in Pennsylvania ...........................................................6 Engaging with the Community for Impact .................................................................8 Pitt Partnering as an Economic Driver .....................................................................11 Innovation and Entrepreneurship ..............................................................................12 Pitt Ventures ....................................................................................................................13

  • Blood Products Advisory Committee March 21, 2019 Meeting Transcript- Topic 3

    FOOD AND DRUG ADMINISTRATION (FDA) Center for Biologics Evaluation and Research (CBER) th 120 Meeting of the Blood Products Advisory Committee OPEN PUBLIC MEETING FDA White Oak Campus 10903 New Hampshire Avenue Silver Spring, MD 20993 March 21, 2019 This transcript appears as received from the commercial transcribing service after inclusion of minor corrections to typographical and factual errors as recommended by the DFO. PARTICIPANTS Richard M. Kaufman, M.D. Brigham and Women’s Hospital Prabhakara Atreya, PhD Food and Drug Administration (FDA) UCLA- Division of Pediatric Judith Baker, Dr.PH, MHSA Hematology/Oncology Sridhar V. Basavaraju, M.D. Centers for Disease Control and Prevention Evan Bloch, M.D., M.S. Johns Hopkins University School of Medicine Barbara Bryant, M.D. University of Texas Medical Branch Meera B. Chitlur, M.D. Wayne State University Bureau of Infectious Disease and Laboratory Alfred DeMaria, M.D. Science Walter Reed National Military Medical Michael DeVan, M.D. Center Roger Lewis, M.D., Ph.D. Harbor-UCLA Medical Center Thomas Ortel, M.D., Ph.D. Duke University Medical Center Martin Schreiber, M.D. Oregon Health & Sciences University Amy Shapiro, M.D. Indiana Hemophilia and Thrombosis Center Jack Stapleton, M.D. University of Iowa Susan L. Stramer, Ph.D. American Red Cross F. Blaine Hollinger, M.D. Baylor College of Medicine Christopher Templin Patient Representative Anne Eder, M.D., Ph.D. Office of Blood Research and Review, FDA Mindy Goldman, M.D. Canadian Blood Services John Brooks, M.D. Centers for Disease Control and Prevention 3 Office of Biostatistics and Epidemiology, Alan Williams, Ph.D.
  • Hematology/ Oncology

    Hematology/ Oncology

    DIVISION OF HEMATOLOGY/ ONCOLOGY DEPARTMENT OF MEDICINE ANNUAL REPORT FY20 DIVISION OF HEMATOLOGY/ONCOLOGY ANNUAL REPORT TABLE OF CONTENTS Message from the Chief 3 Faculty Listing 4 Clinical Activities 7 Quality Improvement Initiatives 13 Clinical Locations 14 Research Activities 16 Grants and Contracts Awarded 65 Teaching Activities 74 One-Year Bibliography 83 Acknowledgments 96 DIVISION OF HEMATOLOGY/ONCOLOGY he major priorities within the Division continue Tto focus on the recruitment of physician- scientists, the reorganization of the clinical services, and the education and training of hematology- Edward Chu, MD Chief oncology fellows and Internal Medicine housestaff. We are pleased to highlight the following faculty recogni- The Division continues to concen- trate on the recruitment of phy- tions and awards in FY 2019-2020: sician-scientists and research sci- • Michael Boyiadzis, MD, was promoted to entists to meet strategic needs in Professor of Medicine. He chairs the Society for several key areas. Despite challeng- lmmunotherapy of Cancer (SICT) Committee es with COVID-19, the Division has that is focused on the development of national been able to recruit two new faculty guidelines for the use of immunotherapies in members: acute leukemias. • Yvonne Chao, MD, PhD, will join the faculty as Assistant Professor of • Adam M. Brufsky, MD, PhD, is the PI of the NCI- Medicine specializing in lung cancer, funded UG1 grant that supports the conduct of cancer signaling and invasion and phase 3 clinical trials that are developed by the metastasis. She will be joining the NCI cooperative groups. Lung Cancer Disease Team and be a member of the HCC Cancer Biology • Timothy Burns, MD, PhD, was awarded an NCI Program.
  • Ashi Accredited Laboratories 2021

    Ashi Accredited Laboratories 2021

    ASHI ACCREDITED LABORATORIES 2021 1120 Route 73, Suite 200 Mount Laurel, NJ 08054 Phone: 856-638-0428 Fax: 856-439-0525 www.ashi-hla.org Updated: February 2021 Histocompatibility Laboratories Histocompatibility laboratories are organized alphabetically by state and institution, followed by those in countries outside the United States. Each laboratory has a current address, director, supervisor (if applicable), phone and fax numbers. Each has been characterized for tests and accreditation, as follows: Test Performed: Serologic Typing Class I (Serology: Class I) Serologic Typing Class II (Serology: Class II) DNA Typing Class I (DNA: Class I) DNA Typing Class II (DNA: Class II) Next Generation Sequencing (NGS) Flow Cytometry (Flow) MLC (MLC) Monitoring for Engraftment (Mont. For Engraft.) Antibody Screening (Antibody Screening) Antibody Identification (Antibody ID) Crossmatch (Crossmatch) ABO/RH Typing (ABO/RH) ASHI Accreditation Categories: HSC/BM Transplantation: Related Donor (HSC/BM: Related) HSC/BM Transplantation: Unrelated Donor (HSC/BM: Unrelated) Solid Organ Transplantation: Deceased Donor (Solid Organ: Deceased) Solid Organ Transplantation: Live Donor (Solid Organ: Live) Histocompatibility Testing for Other Clinical Purposes (Typing for Non-TX) Transfusion Support (Transfusion Support) 2 UNITED STATES (AL – AR) Alabama 11-6-AZ-03-1 Banner University Medical Center – Tucson 10-3-AL-02-2 HLA Laboratory UAB Comprehensive Transplant Institute Department of Pathology Histocompatibility and Immunogenetics Laboratory 1625 N. Campbell
  • Philip J. Norris University of California San Francisco Prepared: 10/10/2018

    Philip J. Norris University of California San Francisco Prepared: 10/10/2018

    Philip J. Norris University of California San Francisco Prepared: 10/10/2018 CURRICULUM VITAE Name: Philip John Norris Position: Adjunct Professor Department of Laboratory Medicine Clinical Professor Department of Medicine University of California, San Francisco Senior Investigator and Director of Laboratory Sciences, SF Vitalant Research Institute Vice President, Research and Scientific Programs Vitalant Address: Vitalant Research Institute 270 Masonic Avenue San Francisco, CA 94118 Voice: (415) 923-5769 FAX: (415) 567-5899 email: [email protected] WWW: https://research.vitalant.org/Investigators/Philip-Norris EDUCATION: 1985-1989 University of California, Berkeley B.A. Molecular Biology 1985-1989 University of California, Berkeley B.S. Bioengineering 1991-1995 College of Physicians & Surgeons, Columbia University M.D. 1995-1996 The Presbyterian Hospital in the City of New York Intern Internal Medicine 1996-1998 Duke University Medical Center Resident Internal Medicine 1998-2001 Massachusetts General Hospital and FelloW Infectious Diseases Brigham and Women’s Hospital, Harvard University LICENSES, CERTIFICATION: 1995 Diplomate of National Board of Medical Examiners 1996 Diplomate of American Board of Internal Medicine 1996-2010 Board Certified in Internal Medicine 2000-noW Board Certified in Infectious Diseases 2004 California medical license, number A87646 PRINICIPAL POSITIONS HELD: 2002-2003 Massachusetts General Hospital Instructor in Medicine 2004-2012 Vitalant Research Institute Associate Investigator 2012-noW Senior Investigator
  • Cornell University Single Audit Report

    Cornell University Single Audit Report

    Cornell University Report on Federal Awards in Accordance with the Uniform Guidance June 30, 2020 EIN: 15-0532082 Cornell University Index June 30, 2020 Page(s) Report of Independent Auditors .............................................................................................................................. 1–3 Consolidated Financial Statements .......................................................................................................................... 4–6 Notes to Consolidated Financial Statements ......................................................................................................... 7–46 Financial Responsibility Supplemental Schedule ...................................................................................................... 47 Note to Financial Responsibility Supplemental Schedule ......................................................................................... 48 Schedule of Expenditures of Federal Awards ...................................................................................................... 49–73 Notes to Schedule of Expenditures of Federal Awards ............................................................................................. 74 Report of Independent Auditors on Internal Control Over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance with Government Auditing Standards ................................. 75–76 Report of Independent Auditors on Compliance with Requirements That
  • 1 Use of US Blood Donors for National Serosurveillance of SARS-Cov-2 Antibodies

    1 Use of US Blood Donors for National Serosurveillance of SARS-Cov-2 Antibodies

    medRxiv preprint doi: https://doi.org/10.1101/2021.05.01.21255576; this version posted May 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . 1 Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an 2 Expanded National Donor Serosurveillance Program. 3 4 Mars Stone1,2, Clara Di Germanio1, David J. Wright3, Hasan Sulaeman1, Honey Dave1, Rebecca V. 5 Fink3, Edward P. Notari4, Valerie Green5, Donna Strauss6, Debra Kessler6, Mark Destree7, Paula Saa4, 6 Phillip C. Williamson1,5, Graham Simmons1,2, Susan L. Stramer4, Jean Opsomer3, Jefferson M. Jones8, 7 Steven Kleinman9, Michael P. Busch1,2; for the NHLBI Recipient Epidemiology and Donor Evaluation 8 Study-IV-Pediatric (REDS-IV-P) 9 1. Vitalant Research Institute (VRI), San Francisco, CA 10 2. Department of Laboratory Medicine, University of California, San Francisco, CA 11 3. Westat, Rockville, MD 12 4. American Red Cross (ARC), Gaithersburg, MD 13 5. Creative Testing Solutions (CTS), Tempe, AZ 14 6. New York Blood Center (NYBC), New York, NY 15 7. BloodWorks Northwest, Seattle, WA 16 8. Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, Georgia 17 9. University of British Columbia, Victoria, BC, Canada 18 19 Corresponding author: Michael P. Busch MD, PhD. Address: Vitalant Research Institute, 270 20 Masonic Avenue, San Francisco, CA, United States 94118. Phone: 1-415-354-1389.
  • FY 2019 Form 990 Emory University

    FY 2019 Form 990 Emory University

    Clark, Susan P From: [email protected] Sent: Wednesday, July 15, 2020 1:05 PM To: Clark, Susan P Cc: Clark, Susan P Subject: [External] Emory University 2018 Form 990 has been Accepted! Dear Susan: Congratulations! The 2018 Form 990 for Emory University has been accepted by the IRS. Regards, Crowe LLP (CTRAC Team) This email message is from Crowe LLP or one of its subsidiaries and may contain privileged or confidential information or other information exempt from disclosure under applicable law. If you are not the intended recipient, please notify the sender by reply email immediately and delete this message without reading further or forwarding to others. This email is not intended to be a contract or other legally binding obligation, and any tax advice expressed in this email should not be construed as a formal tax opinion unless expressly stated. Visit www.crowe.com/disclosure for more information about Crowe LLP and its subsidiaries. 1 Form 990 (2018) Page 2 Part III Statement of Program Service Accomplishments Check if Schedule O contains a response or note to any line in this Part III . ✔ 1 Briefly describe the organization’s mission: EMORY UNIVERSITY'S MISSION IS TO CREATE, PRESERVE, TEACH, AND APPLY KNOWLEDGE IN THE SERVICE OF HUMANITY. (SEE SCHEDULE O FOR CONTINUATION) 2 Did the organization undertake any significant program services during the year which were not listed on the prior Form 990 or 990-EZ? . Yes No If “Yes,” describe these new services on Schedule O. 3 Did the organization cease conducting, or make significant changes in how it conducts, any program services? .
  • Thank You to Members of NIAID Peer Review Groups and Advisory Committees

    Thank You to Members of NIAID Peer Review Groups and Advisory Committees

    Thank You to Members of NIAID Peer Review Groups and Advisory Committees NIH's ability to fund outstanding science hinges in large part on the generosity of scientists and lay people who serve on its hundreds of peer review and advisory committees, including our NIAID Council Members. Learn more about Serving on a Peer Review Committee and how to become a peer reviewer. Whether you traveled to the Washington, D.C., area or participated by teleconference, you donated valuable time and effort to make an enormous and irreplaceable contribution to biomedical science. In recognition, we'd like to take a moment to thank people who participated on NIAID peer review groups, listed below. We'd also like to thank the people who serve on the Center for Scientific Review Study Sections for NIAID applications, though we do not list you individually here. List of Fiscal Year 2020 NIAID Peer Review Group Members These data are sorted by name. To search for a name or organizational affiliation, use control-F (command-F for Mac). Send questions or corrections to [email protected]. Name Affiliation Abazeed, Mohamed E., M.D., Ph.D. Northwestern University Abbate, Antonio, M.D., Ph.D. Virginia Commonwealth University Abimiku, Alash'Le G., Ph.D. University of Maryland, Baltimore Abramovitch, Robert B., Ph.D. Michigan State University Aceves, Seema S., M.D., Ph.D. University of California, San Diego Acharya, Abhinav, Ph.D. Arizona State University Ackerman, Steven Jules, Ph.D. University of Illinois at Chicago Adachi, Roberto, M.D. University of Texas MD Anderson Cancer Center Adamko, Darryl, M.D.